|
1
|
Cullen P: Evidence that triglycerides are
an independent coronary heart disease risk factor. Am J Cardiol.
86:943–949. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Azhar S: Peroxisome proliferator-activated
receptors, metabolic syndrome and cardiovascular disease. Future
Cardiol. 6:657–691. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu MH, Chu CH, Chou YC, Chou WY, Yang T,
Hsu GC, Yu CP, Yu JC and Sun CA: Joint effect of peroxisome
proliferator-activated receptor γ genetic polymorphisms and
estrogen-related risk factors on breast cancer risk: results from a
case-control study in Taiwan. Breast Cancer Res Treat. 127:777–784.
2011.
|
|
4
|
Schoonjans K, Staels B and Auwerx J: Role
of the peroxisome proliferator-activated receptor (PPAR) in
mediating the effects of fibrates and fatty acids on gene
expression. J Lipid Res. 37:907–925. 1996.PubMed/NCBI
|
|
5
|
Chawla A, Barak Y, Nagy L, Liao D,
Tontonoz P and Evans RM: PPAR-gamma dependent and independent
effects on macrophage-gene expression in lipid metabolism and
inflammation. Nat Med. 7:48–52. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Swarbrick MM, Chapman CM, McQuillan BM,
Hung J, Thompson PL and Beilby JP: A Pro12Ala polymorphism in the
human peroxisome proliferator-activated receptor-gamma 2 is
associated with combined hyperlipidaemia in obesity. Eur J
Endocrinol. 144:277–282. 2001. View Article : Google Scholar
|
|
7
|
Tavares V, Hirata RD, Rodrigues AC, Monte
O, Salles JE, Scallissi N, Speranza AC, Gomes S and Hirata MH:
Effect of the peroxisome proliferator-activated receptor-gamma
C161T polymorphism on lipid profile in Brazilian patients with Type
2 diabetes mellitus. J Endocrinol Invest. 28:129–136. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barbieri M, Rizzo MR, Papa M, Acampora R,
De Angelis L, Oliviri F, Marchegiani F, Franceschi C and Paolisso
G: Role of interaction between variants in the PPARG and
interleukin-6 genes on obesity related metabolic risk factors. Exp
Gerontol. 40:599–604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yilmaz-Aydogan H, Kurnaz O, Kurt O,
Akadam-Teker B, Kucukhuseyin O, Tekeli A and Isbir T: Effects of
the PPARG P12A and C161T gene variants on serum lipids in coronary
heart disease patients with and without Type 2 diabetes. Mol Cell
Biochem. 358:355–363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu XS, Guo ZR, Zhou H, Shi ZM, Wu M, Zhang
J, Sun GX, Zhou ZY, Pan XQ and Yao CL: Study on the prevalence of
metabolic syndrome among 35–74 year-olds in Jiangsu province.
Zhonghua Liu Xing Bing Xue Za Zhi. 27:751–756. 2006.(In
Chinese).
|
|
11
|
Clement K, Hercberg S, Passinge B, Galan
P, Varroud-Vial M, Shuldiner AR, Beamer BA, Charpentier G,
Guy-Grand B, Froguel P and Vaisse C: The Pro115Gln and Pro12Ala
PPAR gamma gene mutations in obesity and type 2 diabetes. Int J
Obes Relat Metab Disord. 24:391–393. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hara K, Okada T, Tobe K, Yasuda K, Mori Y,
Kadowaki H, Hagura R, Akanuma Y, Kimura S, Ito C and Kadowaki T:
The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to
type 2 diabetes. Biochem Biophys Res Commun. 271:212–216. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Doney A, Fischer B, Frew D, Cumming A,
Flavell DM, World M, Montgomery HE, Boyle D, Morris A and Palmer
CN: Haplotype analysis of the PPARgamma Pro12Ala and C1431T
variants reveals opposing associations with body weight. BMC Genet.
3:212002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iwata E, Matsuda H, Fukuda T, Fukuen S,
Motomura T, Igarashi T, Yamamoto I and Azuma J: Mutations of the
peroxisome proliferator-activated receptor gamma (PPARgamma) gene
in a Japanese population: the Pro12Ala mutation in PPAR gamma 2 is
associated with lower concentrations of serum total and non-HDL
cholesterol. Diabetologia. 44:1354–1355. 2001. View Article : Google Scholar
|
|
15
|
Tai ES, Corella D, Deurenberg-Yap M,
Adiconis X, Chew SK, Tan CE and Ordovas JM: Differential effects of
the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids
and diabetes risk in an Asian population. J Lipid Res. 45:674–685.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brand-Herrmann SM, Kuznetsova T, Wiechert
A, Stolarz K, Tikhonoff V, Schmidt-Petersen K, Telgmann R, Casiglia
E, Wang JG, Thijs L, Staessen JA and Brand E: European Project on
Genes in Hypertension Investigators: Alcohol intake modulates the
genetic association between HDL cholesterol and the PPARgamma2
Pro12Ala polymorphism. J Lipid Res. 46:913–919. 2005. View Article : Google Scholar
|
|
17
|
Pollex RL, Mamakeesick M, Zinman B, Harris
SB, Hegele RA and Hanley AJ: Peroxisome proliferator-activated
receptor gamma polymorphism Pro12Ala is associated with nephropathy
in type 2 diabetes. J Diabetes Complications. 21:166–171. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beamer BA, Yen CJ, Andersen RE, Muller D,
Elahi D, Cheskin LJ, Andres R, Roth J and Shuldiner AR: Association
of the Pro12Ala variant in the peroxisome proliferator-activated
receptor-gamma2 gene with obesity in two Caucasian populations.
Diabetes. 47:1806–1808. 1998. View Article : Google Scholar
|
|
19
|
Zhou X, Chen J and Xu W: Association
between C1431T polymorphism in peroxisome proliferator-activated
receptor-γ gene and coronary artery disease in Chinese Han
population. Mol Biol Rep. 39:1863–1868. 2012.
|
|
20
|
Patil N, Berno AJ, Hinds DA, Barrett WA,
Doshi JM, Hacker CR, Kautzer CR, Lee DH, Marjoribanks C, McDonough
DP, Nguyen BT, Norris MC, Sheehan JB, Shen N, Stern D, Stokowski
RP, Thomas DJ, Trulson MO, Vyas KR, Frazer KA, Fodor SP and Cox DR:
Blocks of limited haplotype diversity revealed by high-resolution
scanning of human chromosome 21. Science. 294:1719–1723. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu SJ, Guo ZR, Zhou ZY, Hu XS and Wu M:
PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in
a Chinese Han population. Lipids Health Dis. 13:232014.
|
|
22
|
Semple RK, Chatterjee VK and O’Rahilly S:
PPAR gamma and human metabolic disease. J Clin Invest. 116:581–589.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deeb SS, Fajas L, Nemoto M, Pihlajamäki J,
Mykkänen L, Kuusisto J, Laakso M, Fujimoto W and Auwerx J: A
Pro12Ala substitution in PPARgamma2 associated with decreased
receptor activity, lower body mass index and improved insulin
sensitivity. Nat Genet. 20:284–287. 1998. View Article : Google Scholar
|
